Rivastigmine for the Prevention of Postoperative Delirium After Cardiac Surgery

NCT00257868 Phase 3 COMPLETED

The purpose of this study is to determine whether Rivastigmine is effective for the prevention of postoperative delirium in patients undergoing cardiac surgery.

Details

Lead sponsor	University Hospital, Basel, Switzerland
Phase	Phase 3
Status	COMPLETED
Enrolment	120
Start date	2006-01
Completion	2007-07

Conditions

• Delirium

Interventions

• Rivastigmine prevention of delirium

Primary outcomes

• Development of postoperative delirium within 7 days after cardiac surgery

Countries

Switzerland